The Clearity Foundation was launched in 2008 to help ovarian cancer patients and their physicians make better-informed treatment decisions, based on molecular profiling of tumors. The Clearity team includes scientists, physicians, and volunteers who feel passionately that the paradigm for ovarian cancer treatment needs to change from a trial-and-error approach to one that that individualizes therapy selection based on each patient’s tumor molecular profile. What We Do The Clearity Foundation is a 501(c)(3) not-for-profit organization that provides patient support services including lab test coordination, tumor blueprint interpretation, and clinical trial identification free of charge. Our services and educational programs are focused on: Assisting patients and physicians prioritize therapy options for recurrent and refractory ovarian cancer by providing information about the tumor molecular profile; Helping patients find clinical trials for which they may be eligible, based on the molecular characteristics of their tumor; Educating patients and physicians about the value of molecular profiling in ovarian cancer diagnosis and treatment; and Expediting the clinical development of novel targeted agents for ovarian cancer by creating a database that correlates tumor molecular profiles with treatment outcomes.